HCAR1 and breast carcinoma: Beyond breast cancer, in lung cancer cells, GPR81 activation reduces intracellular cyclic adenosine monophosphate (cAMP) levels and inhibits protein kinase A (PKA) activity, leading to the activation of the transcriptional coactivator TAZ.